0.2387
3.20%
-0.0079
After Hours:
.2538
0.0151
+6.33%
Asensus Surgical Inc stock is currently priced at $0.2387, with a 24-hour trading volume of 1.14M.
It has seen a -3.20% decreased in the last 24 hours and a +8.50% rose in the past month.
The chart indicates a potential bearish trend, as the stock is below the $0.2468 pivot point. If it approaches the $0.2349 support level, significant changes may occur.
Previous Close:
$0.2466
Open:
$0.2433
24h Volume:
1.14M
Market Cap:
$64.92M
Revenue:
$5.61M
Net Income/Loss:
$-79.09M
P/E Ratio:
-0.7021
EPS:
-0.34
Net Cash Flow:
$-65.17M
1W Performance:
-1.77%
1M Performance:
+8.50%
6M Performance:
+13.50%
1Y Performance:
-61.89%
Asensus Surgical Inc Stock (ASXC) Company Profile
Name
Asensus Surgical Inc
Sector
Industry
Phone
919 765 8400
Address
635 Davis Drive, Suite 300, Morrisville
Asensus Surgical Inc Stock (ASXC) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Sep-08-22 | Initiated | Cantor Fitzgerald | Overweight |
May-26-21 | Initiated | H.C. Wainwright | Buy |
Asensus Surgical Inc Stock (ASXC) Latest News
Asensus Surgical Announces Sendai Tokushukai Hospital in Japan to Initiate Senhance Surgery Program
GlobeNewswire Inc.
Wayfair To Rally Over 28%? Here Are 10 Top Analyst Forecasts For Thursday
Benzinga
Asensus Surgical, Inc. Announces Non-Binding Acquisition Proposal and Exclusivity Arrangement with KARL STORZ SE & Co. KG
GlobeNewswire Inc.
Asensus Surgical, Inc. Reports Operating and Financial Results for the Fourth Quarter 2023 and Full Year 2023
GlobeNewswire Inc.
Asensus Surgical, Inc. Schedules Fourth Quarter and Full Year 2023 Financial and Operating Results Conference Call for March 21, 2024
GlobeNewswire Inc.
Asensus Surgical to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference
GlobeNewswire Inc.
Asensus Surgical Inc Stock (ASXC) Financials Data
Asensus Surgical Inc (ASXC) Revenue 2024
ASXC reported a revenue (TTM) of $5.61 million for the quarter ending September 30, 2023, a -20.97% decline year-over-year.
Asensus Surgical Inc (ASXC) Net Income 2024
ASXC net income (TTM) was -$79.09 million for the quarter ending September 30, 2023, a -7.53% decrease year-over-year.
Asensus Surgical Inc (ASXC) Cash Flow 2024
ASXC recorded a free cash flow (TTM) of -$65.17 million for the quarter ending September 30, 2023, a -9.55% decrease year-over-year.
Asensus Surgical Inc (ASXC) Earnings per Share 2024
ASXC earnings per share (TTM) was -$0.33 for the quarter ending September 30, 2023, a -6.45% decline year-over-year.
About Asensus Surgical Inc
Asensus Surgical, Inc. engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery. It digitizes the interface between the surgeon and the patient to improve minimally invasive surgery through a new category of care called Digital Laparoscopy. The company's digital interface enables the use of capabilities, such as augmented intelligence, connectivity, and robotics in laparoscopy, as well as allows to address the current clinical, cognitive, and economic shortcomings in surgery. The company's products include Senhance Surgical System, a multi-port robotic surgery system that allows multiple robotic arms to control instruments and a camera; and SurgiBot System, a single-port system robotically enhanced laparoscopic surgical platform. It offers its products directly and through distributors in Europe, the United States, Japan, Taiwan, and internationally. The company was formerly known as TransEnterix, Inc. and changed its name to Asensus Surgical, Inc. in February 2021. Asensus Surgical, Inc. was founded in 2006 and is based in Morrisville, North Carolina.
Cap:
|
Volume (24h):